Enter your email address:

Delivered by FeedBurner

Johnson & Johnson expects nod for Covid vaccine by early 2021: Paul Stoffels, chief scientific officer, J&J

Scientists and drug companies across the world are accelerating
various treatments and vaccine options to tackle Covid-19, which has
claimed hundreds of thousands of lives and crippled the world economy.
J&J, along with companies like GSK-Sanofi, AstraZeneca, Moderna, and
Sinovac are in the forefront of the race for vaccine development.



Post a Comment